Synthes
| Formerly | Synthes-Stratec |
|---|---|
| Company type | Subsidiary |
| SIX: SYST | |
| Industry | Health care |
| Founded | 1999 |
| Headquarters | Solothurn, Switzerland (corporate), West Chester, Pennsylvania, United States (operational) |
Key people | Michel Orsinger (president and CEO) |
| Products | Physical trauma, spine, craniofacial, mandible and chest implants, medical power tools, biomaterials |
| Revenue | US $3.687 billion (2010) |
| US $1.283 billion (2010) | |
| US $907.7 million (2010) | |
| Total assets | US $7.924 billion (end 2010) |
| Total equity | US $6.739 billion (end 2010) |
Number of employees | 11,430 (end 2010) |
| Parent | Johnson & Johnson |
| Website | synthes |
Synthes Holding AG (formerly Synthes-Stratec) is a multinational medical device manufacturer based in Solothurn, Switzerland and West Chester, Pennsylvania, United States. It is the world's largest maker of implants to mend bone fractures, and also produces surgical power tools and advanced biomaterials.
In June 2012 Synthes was sold by its chairman, former CEO and largest shareholder Hansjörg Wyss to Johnson & Johnson for $20.2 billion. The company is part of Johnson & Johnson MedTech business segment.